Manipal Health Enterprises' Rs 9,275-crore IPO entered Day 2 of bidding with a muted response from investors, while the grey market premium (GMP) remained modest at around 2%. The issue, backed by Temasek and healthcare entrepreneur Ranjan Pai, has seen cautious participation so far, prompting investors to weigh whether the IPO is worth betting on.
On Day 1, the IPO was subscribed 15% overall, with bids received for 15% of the 9 crore shares on offer. The retail investor portion was subscribed 25% against the 1.64 crore shares reserved for the category.